Willow Biosciences (TSE:WLLW) Shares Up 14.3% – Should You Buy?

Willow Biosciences Inc. (TSE:WLLWGet Free Report)’s stock price rose 14.3% during mid-day trading on Tuesday . The company traded as high as C$0.04 and last traded at C$0.04. Approximately 314,000 shares were traded during trading, a decline of 26% from the average daily volume of 424,405 shares. The stock had previously closed at C$0.04.

Willow Biosciences Stock Performance

The stock’s 50-day moving average is C$0.04 and its 200-day moving average is C$0.07. The company has a current ratio of 0.80, a quick ratio of 19.71 and a debt-to-equity ratio of 902.05. The stock has a market cap of C$5.79 million, a price-to-earnings ratio of -0.73 and a beta of 1.13.

About Willow Biosciences

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Recommended Stories

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.